Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.72m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Update on Impression Technologies Limited

30 May 2024 15:16

RNS Number : 5197Q
Mercia Asset Management PLC
30 May 2024
 

RNS

 30 May 2024

 

Mercia Asset Management PLC

 

("Mercia", the "Company" or the "Group")

 

Update on Impression Technologies Limited

 

 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with over £1.5 billion of assets under management, announces that it has made the decision to cease further funding for one of its direct investments, Impression Technologies Limited ("ITL").

 

Mercia first invested in ITL via its thirds-party funds in 2014 and it became a balance sheet direct investment in 2015. During the period of Mercia's investment, ITL developed its novel Hot Form Quench ("HFQ®") technology, established a low volume manufacturing facility, secured its first production customers, signed licences with several automotive sub-contractors and developed its technology to be transferable across industry sectors e.g. aerospace.

 

However, despite this considerable technological and commercial progress, ITL has been unable to reach breakeven. As announced on 28 November 2023, Mercia reduced its direct investment carrying value in its interim results, reflecting increased uncertainty following a sale process which did not ultimately succeed. Since that time, ITL has continued to explore options including further funding or a sale. Ultimately however, no successful new external funding or a sale of ITL has been achieved. Given that ITL's pathway to profitability remains highly uncertain, Mercia has also decided to cease further funding. It is now anticipated that ITL will enter into an insolvency process in the near future.

 

Mercia will now reduce the carrying value of its investment in ITL as at 31 March 2024 to zero, resulting in a small reduction in the Group's net asset value per share of c.2 pence, compared with the net asset value per share of 45.3 pence as at 30 September 2023.

 

Dr Mark Payton, CEO of Mercia Asset Management PLC, said: "Mercia's year to 31 March 2024 has demonstrated the variability of venture investing, from the very successful and profitable sale of the Group's direct investment in nDreams for £30.2million, to the difficult decision to cease further investment into Impression Technologies Limited, after a decade of supporting its management team and its proven HFQ® technology. Despite our full support and ITL's best efforts, it has failed to reach breakeven or identify a suitable next-stage investor.

 

"Investment discipline is at the heart of Mercia's investing philosophy and long-term performance. Therefore, having explored all available options, we have reached this decision to cease further funding into ITL."

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this announcement, this inside information is now considered to be in the public domain.

 

- Ends -

 

For further information, please contact:

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

 

+44 (0)330 223 1430

 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel

Singer Capital Markets (Joint Broker)

+44 (0)20 7496 3000

Harry Gooden, James Moat

FTI Consulting

+44 (0)20 3727 1051

Tom Blackwell, Jenny Boyd

mercia@fticonsulting.com

 

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, private equity, debt and proprietary capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

 

The Group has a strong UK footprint through its regional offices, university partnerships and extensive personal networks, providing it with access to high-quality deal flow.

 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDURASRSNUVOAR
Date   Source Headline
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million
2nd Apr 20207:00 amRNSPortfolio companies collaborate against COVID-19
27th Mar 202011:30 amRNSDirector/PDMR Dealings
25th Mar 20203:08 pmRNSCOVID-19 Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.